{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:41:48Z","timestamp":1760107308700,"version":"build-2065373602"},"reference-count":23,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2008,4,1]],"date-time":"2008-04-01T00:00:00Z","timestamp":1207008000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,4,1]],"date-time":"2008-04-01T00:00:00Z","timestamp":1207008000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revue de Pneumologie Clinique"],"published-print":{"date-parts":[[2008,4]]},"DOI":"10.1016\/j.pneumo.2008.04.002","type":"journal-article","created":{"date-parts":[[2008,6,6]],"date-time":"2008-06-06T04:41:18Z","timestamp":1212727278000},"page":"81-84","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["An\u00e9mie et cancer bronchique"],"prefix":"10.1016","volume":"64","author":[{"given":"J.-M.","family":"Br\u00e9chot","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.-F.","family":"Mor\u00e8re","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pneumo.2008.04.002_bib1","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0761-8417(05)84778-9","article-title":"pour le Groupe d\u2019oncologie de la Soci\u00e9t\u00e9 de pneumologie de langue fran\u00e7aise. Prise en charge de l\u2019an\u00e9mie et des m\u00e9tastases osseuses dans les cancers bronchiques non \u00e0 petites cellules metastases","volume":"61","author":"Br\u00e9chot","year":"2005","journal-title":"Rev Pneumol Clin"},{"key":"10.1016\/j.pneumo.2008.04.002_bib2","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.lungcan.2005.08.004","article-title":"Anemia profiles in patients with lung cancer: what have we learned from the European Cancer Anaemia Survey (ECAS)?","volume":"50","author":"Kosmidis","year":"2005","journal-title":"Lung Cancer"},{"issue":"8 suppl","key":"10.1016\/j.pneumo.2008.04.002_bib3","doi-asserted-by":"crossref","first-page":"S841","DOI":"10.1097\/01.JTO.0000284356.78908.b2","article-title":"High prevalence of anemia among french hospitalised cancer patients: a one-day cross-sectional survey","volume":"2","author":"Lemari\u00e9","year":"2007","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.pneumo.2008.04.002_bib4","doi-asserted-by":"crossref","first-page":"4083","DOI":"10.1200\/JCO.2002.07.177","article-title":"Use of epoetin in patients with cancer: evidence-based clinical practice guidelines of the ASCO\/ASH","volume":"20","author":"Rizzo","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.pneumo.2008.04.002_bib5","unstructured":"Rodgers GM, Cella D, Chanan-Khan A, Cheney C, Cleeland C, Coccia PF, et al. Cancer and treatment-related anemia. National Comprehensive Cancer Network clinical practice guidelines in oncology, v1.2006. Available at: www.nccn.org. Accessed April 3, 2006."},{"key":"10.1016\/j.pneumo.2008.04.002_bib6","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.ejca.2006.10.014","article-title":"EORTC taskforc for the elderly. EORTC guidelines for the use of erythropoietic proteins in anaemic patients with cancer: 2006 update","volume":"43","author":"Bokemeyer","year":"2007","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.pneumo.2008.04.002_bib7","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1093\/jnci\/94.16.1211","article-title":"Double-blind, placebo-controlled, randomized phase III trial of darpoetin alpha in lung cancer patients receiving chemotherapy","volume":"94","author":"Vansteenkiste","year":"2002","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.pneumo.2008.04.002_bib8","doi-asserted-by":"crossref","first-page":"9377","DOI":"10.1200\/JCO.2005.01.8507","article-title":"Efficacy and safety analysis of epoetin alpha in patients with small-cell lung cancer: a randomized, double-blind, placebo-controlled trial","volume":"23","author":"Grote","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.pneumo.2008.04.002_bib9","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1200\/JCO.2006.07.1514","article-title":"Randomized, double-blind, placebo-controlled trial of erythropoietin in non-small-cell lung cancer with disease-related anemia","volume":"25","author":"Wright","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.pneumo.2008.04.002_bib10","doi-asserted-by":"crossref","first-page":"S433","DOI":"10.1097\/01.JTO.0000283344.69129.a5","article-title":"A phase 3 randomized, double blind, placebo-controlled study of patients with previously untreated extensive-stage small cell lung cancer (SCLC) treated with platinum plus etoposide chemotherapy with or without darpoetin alpha","volume":"2","author":"Pirker","year":"2007","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.pneumo.2008.04.002_bib11","first-page":"716","article-title":"Targeting anemia in patients with lung cancer","volume":"1","author":"Crawford","year":"2006","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.pneumo.2008.04.002_bib12","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1056\/NEJMoa011931","article-title":"Pure red-cell aplasia and antierythropoietin antibodies in patients treated with recombinant erythropoietin","volume":"346","author":"Casadevall","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pneumo.2008.04.002_bib13","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/S0140-6736(03)14567-9","article-title":"Erythropoietin to treat head and neck cancer patients with anemia undergoing radiotherapy: randomized, double-blind, placebo-controlled trial","volume":"362","author":"Henke","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.pneumo.2008.04.002_bib14","doi-asserted-by":"crossref","first-page":"5960","DOI":"10.1200\/JCO.2005.06.150","article-title":"Maintaining normal hemoglobin levels with epoetin alpha in mainly nonanemic patients with metastatic breast cancer receiving first-line chemotherapy: a survival study","volume":"23","author":"Leyland-Jones","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.pneumo.2008.04.002_bib15","doi-asserted-by":"crossref","first-page":"S352","DOI":"10.1097\/01.JTO.0000283177.55684.d0","article-title":"Assessing the role of erythroid stimulating agents (ESAs): a comprehensive review of benefits and risks based on 8 randomized studies in 2023 patients with respiratory cancers","volume":"2","author":"Raftopoulos","year":"2007","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.pneumo.2008.04.002_bib16","doi-asserted-by":"crossref","first-page":"S245","DOI":"10.1097\/01.JTO.0000283021.57014.94","volume":"2","author":"Pirker","year":"2007","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.pneumo.2008.04.002_bib17","doi-asserted-by":"crossref","first-page":"4708","DOI":"10.1200\/JCO.2006.06.2737","article-title":"Do erythropoietin receptors on cancers cells explain unexpected clinical findings?","volume":"24","author":"Henke","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.pneumo.2008.04.002_bib18","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1056\/NEJMp078112","article-title":"Do cancer cells express fonctional erythropoietin receptors?","volume":"356","author":"Longmore","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pneumo.2008.04.002_bib19","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1056\/NEJMp078101","article-title":"Weighing the hazards of erythropoiesis stimulation in patients with cancer","volume":"356","author":"Khuri","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pneumo.2008.04.002_bib20","doi-asserted-by":"crossref","first-page":"4825","DOI":"10.1158\/1078-0432.CCR-06-3061","article-title":"Erythropoietin and erythropoietin receptor coexpression is associated with poor survival in stage I non-small cell lung cancer","volume":"13","author":"Saintigny","year":"2007","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.pneumo.2008.04.002_bib21","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1056\/NEJMp078100","article-title":"Erythropoietin, the FDA, and oncology","volume":"356","author":"Steinbrook","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pneumo.2008.04.002_bib22","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1200\/JCO.2006.08.8153","article-title":"Erythropoietin: high profile, high scrutiny","volume":"25","author":"Crawford","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.pneumo.2008.04.002_bib23","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.lungcan.2005.10.024","article-title":"Routine once-weekly darpoietin alpha administration is cost-effective in lung cancer patients with chemotherapy-induced anemia: a Markov analysis","volume":"51","author":"Borget","year":"2006","journal-title":"Lung Cancer"}],"container-title":["Revue de Pneumologie Clinique"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0761841708000072?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0761841708000072?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:12:07Z","timestamp":1760105527000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0761841708000072"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,4]]},"references-count":23,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,4]]}},"alternative-id":["S0761841708000072"],"URL":"https:\/\/doi.org\/10.1016\/j.pneumo.2008.04.002","relation":{},"ISSN":["0761-8417"],"issn-type":[{"type":"print","value":"0761-8417"}],"subject":[],"published":{"date-parts":[[2008,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An\u00e9mie et cancer bronchique","name":"articletitle","label":"Article Title"},{"value":"Revue de Pneumologie Clinique","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pneumo.2008.04.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}